AboutRebecca Limestall

Rebecca directs the delivery of Sg2 intelligence via educational offerings such as conferences, courses and webinars. She oversees Sg2’s flagship annual conference series, the Sg2 Executive Summit, which presents thought leadership and strategic advice to more than 1,500 health care executives across the US. As leader of Sg2 Education, she plans strategic retreats, courses and expert presentations for all segments of the health care industry, including health systems and industry partners, such as pharmaceutical and device companies.

Rebecca works with a team of more than 30 expert faculty members to ensure the latest research and aligned intelligence is provided to Sg2 clients. Additionally, she is a frequent presenter and facilitator at Sg2 educational events, conferences and client education sessions. She has developed curricula and led sessions on various topics, including evolving strategic planning, developing a service line portfolio, creating an integrated System of CARE and understanding the impact of future-focused trends on specific service lines.

Prior to taking on her education role, Rebecca led Sg2’s women’s health and pediatrics offerings and products. As a seasoned expert, Rebecca continues to guide organizations in making strategic decisions across the care continuum for women and children’s health.

Before joining Sg2, Rebecca worked in a variety of health care settings, including for-profit and nonprofit hospitals, medical product manufacturers, and a retail pharmacy. She has experience in management, market research, pharmacoeconomics, forecasting and patient relations.

Rebecca received a master of business administration from the Stephen M Ross School of Business at the University of Michigan and a master of health services administration from the University of Michigan School of Public Health. She earned a bachelor of business administration magna cum laude from the University of Georgia.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube